Filing Flows › Ovid Therapeutics (OVID) › Q4 2025 › vs Q4 2024
Ovid Therapeutics (OVID) Q4 2025 vs Q4 2024 (year over year)
Ovid Therapeutics's revenue rose $642K (+845%) from $76K in Q4 2024 to $718K in Q4 2025.
Ovid Therapeutics, Q4 2025: revenue $718K (+845% year over year), net earnings $9.7M, operating cash flow −$10.4M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q4 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $718K | $76K | $642K | +845% |
| Other income, net | $22.0M | $1.5M | $20.5M | 15× |
| Costs & expenses | $22.7M | $10.8M | $11.9M | +110% |
| Operating costs | $13.0M | $10.8M | $2.2M | +20% |
| Net earnings | $9.7M | −$9.3M | $18.9M | — |
| Research & development | $6.6M | $5.9M | $666K | +11% |
| General & admin | $6.4M | $4.9M | $1.5M | +32% |
| Operating cash sources | $21.3M | $2.2M | $19.1M | +879% |
| Depreciation & amortization | $17K | $160K | −$143K | -89% |
| Share-based compensation | $1.2M | $1.3M | −$65K | -5% |
| Cash used in operations | $10.4M | $10.0M | $400K | +4% |
| Working capital & other | $21.3M | $2.2M | $19.1M | +879% |
Questions
How much did Ovid Therapeutics's revenue grow year over year in Q4 2025?
Ovid Therapeutics's revenue rose $642K (+845%) from $76K in Q4 2024 to $718K in Q4 2025.